[Reactive oligonucleotide derivatives as potential antiviral preparations].
Knorre
D G
DG
Vlasov
V V
VV
D000818:Animals; D000998:Antiviral Agents / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D055598:Chemical Phenomena; D002621:Chemistry; D002642:Chick Embryo; D004247:DNA / Q000378:metabolism; D004279:DNA, Viral / Q000378:metabolism / Q000494:pharmacology; D004353:Drug Evaluation, Preclinical; D004347:Drug Interactions; D066298:In Vitro Techniques; D009690:Nucleic Acid Conformation / Q000187:drug effects; D009841:Oligonucleotides / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D011487:Protein Conformation / Q000187:drug effects; D012313:RNA / Q000378:metabolism; D012367:RNA, Viral / Q000378:metabolism / Q000494:pharmacology; D013329:Structure-Activity Relationship; D014764:Viral Proteins / Q000494:pharmacology; D014777:Virus Diseases / Q000188:drug therapy; D014779:Virus Replication / Q000187:drug effects
D000998:Antiviral Agents; D004279:DNA, Viral; D009841:Oligonucleotides; D012367:RNA, Viral; D014764:Viral Proteins; D012313:RNA; D004247:DNA
Reaktsionnosposobnye proizvodnye oligonukleotidov kak potentsial'nye protivovirusnye preparaty.